1.Date of the board of directors resolution:2026/03/04

2.General shareholders' meeting date:2026/05/15

3.General shareholders' meeting location:TOP PHARM. MEDICALWARE COMPANY LIMITED(20F., No. 499, Zhongming S. Rd., West Dist., Taichung City

4.Cause for convening the meeting I.Reported matters:
(1)Year 2025 Business Report
(2)Supervisors' Review Report on the year 2025 Financial Statements
(3)Report on Employee's and Directors' Remuneration for the year 2025

5.Cause for convening the meeting II.Acknowledged matters:
(1)Year 2025 Business Report and Financial Statements
(2)Year 2025 Earnings Distribution

6.Cause for convening the meeting III, Matters for Discussion:
(1)Approved of the new share issue through capitalization of earnings.
(2)Approved of the establish of ”Rules of Procedure for Shareholders’Meeting”
(3)Approved of the establish of ”Election Method for Directors and Supervisors”
(4)Approved of the establish of ”Procedures for Acquisition or Disposal of Assets”
(5)Approved of the establish of ”Procedures for Endorsement and Guarantee”
(6)Approved of the establish of ”Procedures for Lending Funds to Other Parties”
(7)Approved of the release the prohibition on Directors from participation incompetitive business.

7.Cause for convening the meeting IV.Election matters:None

8.Cause for convening the meeting V.Other Proposals:None

9.Cause for convening the meeting VI.Extemporary Motions:None

10.Book closure starting date:2026/04/16

11.Book closure ending date:2026/05/15

12.Any other matters that need to be specified:Pursuant to Article 172-1 of the Company Act, a shareholder may submit a written proposal for discussion at a regular shareholders' meeting from 2026/03/31 to 2026/04/10 17:00. Location for shareholders' submission of proposal:20F., No. 499, Zhongming S. Rd., West Dist., Taichung City, Taiwan(R.O.C.)
Tel:(04)2375-9099